StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Emmaus Life Sciences's market cap was $3.51M on Oct 19, 2026, against $593.95K a year earlier. Over the last 5 years it ranged from $19.16K to $106.02M, with a median of $6.18M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$3.51M+322.7%
2025Dec 31, 2025$830.25K+52.9%
2024Dec 31, 2024$542.86K-89.9%
2023Dec 29, 2023$5.37M-58.4%
2022Dec 30, 2022$12.90M-84.3%
2021Dec 31, 2021$82.35M+36.7%
2020Dec 31, 2020$60.25M-19.3%
2019Dec 31, 2019$74.62M+295.2%
2018Dec 31, 2018$18.88M-78.5%
2017Dec 29, 2017$87.71M+807505.4%
2016Dec 30, 2016$10.86K-99.9%
2015Dec 31, 2015$18.45M-86.5%
2014Dec 31, 2014$136.95M-31.6%
2013Dec 31, 2013$200.27M+3495.3%
2012Dec 31, 2012$5.57M-83.5%
2011Dec 30, 2011$33.69M-74.9%
2010Dec 31, 2010$134.45M–

More Emmaus Life Sciences figures

See a number that looks wrong?